Happy butterscotch pudding day from the wBW team! We’ve put together the freshest news from our good industry.

The darkest-darkest timeline is the one where the world’s richest man runs a communications platform in a truly vengeful, ...

The Kiev-class aircraft carriers were the Soviet Union's attempt to project naval power during the Cold War, designed to ...

Furthermore, beyond the immediate trial, there is a broader potential for approval and product launches from Rocket’s lentiviral vector-based therapies, which adds to the investment case. The Phase 2 ...

Analyst Cory Jubinville, PhD of LifeSci Capital maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report), retaining the ...

The company said the single-arm multicenter Phase II trial may support accelerated approval for the RP-A501 gene therapy in the US.

Australia and India are expanding their space collaboration, focusing on supporting India's Gaganyaan mission and launching ...

Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...

A safe environment of protected rights and freedoms. Responsible citizens — responsible for their own development, well-being ...

We're living in an age where technology is advancing very fast. Here are 12 unbelievable high-tech military weapons that ...

Fintel reports that on September 12, 2024, JMP Securities initiated coverage of Rocket Lab USA (NasdaqCM:RKLB) with a Market ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...